Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

ImmunityBio (IBRX) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for ImmunityBio (IBRX) over the last 12 years, with Q3 2025 value amounting to $205.1 million.

  • ImmunityBio's Other Gross PP&E Adjustments rose 257.08% to $205.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.1 million, marking a year-over-year increase of 257.08%. This contributed to the annual value of $182.5 million for FY2024, which is 651.26% up from last year.
  • As of Q3 2025, ImmunityBio's Other Gross PP&E Adjustments stood at $205.1 million, which was up 257.08% from $203.1 million recorded in Q2 2025.
  • ImmunityBio's Other Gross PP&E Adjustments' 5-year high stood at $205.1 million during Q3 2025, with a 5-year trough of $76.5 million in Q4 2021.
  • Its 5-year average for Other Gross PP&E Adjustments is $160.3 million, with a median of $181.9 million in 2023.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 776.64% in 2021, then soared by 9106.34% in 2022.
  • ImmunityBio's Other Gross PP&E Adjustments (Quarter) stood at $76.5 million in 2021, then surged by 91.06% to $146.2 million in 2022, then increased by 17.21% to $171.4 million in 2023, then grew by 6.51% to $182.5 million in 2024, then rose by 12.38% to $205.1 million in 2025.
  • Its last three reported values are $205.1 million in Q3 2025, $203.1 million for Q2 2025, and $204.9 million during Q1 2025.